DarshanTalks Podcast

Podcast tekijän mukaan Darshan Kulkarni

Kategoriat:

382 Jaksot

  1. Key Regulatory Agencies in Pharma M&A

    Julkaistiin: 20.2.2025
  2. Does E6 (R3) Blur the Line Between GCP and Privacy Laws?

    Julkaistiin: 19.2.2025
  3. RFK Jr. Confirmed as HHS Secretary: What It Means for Healthcare Policy

    Julkaistiin: 18.2.2025
  4. America’s Research Future in Jeopardy

    Julkaistiin: 15.2.2025
  5. Trump Administration’s NIH cuts: Will they cripple US medical research?

    Julkaistiin: 14.2.2025
  6. DEI Under Trump: What It Means for Clinical Trials

    Julkaistiin: 13.2.2025
  7. CAPA & RCA: A Must for Pharma M&A

    Julkaistiin: 12.2.2025
  8. Trump Targets Indirect Costs in NIH Funding

    Julkaistiin: 11.2.2025
  9. The USAID Halt and Its Consequences for Clinical Research

    Julkaistiin: 10.2.2025
  10. Ebola Vaccine Trial in Record Time!

    Julkaistiin: 8.2.2025
  11. Your Clinical Trial Site M&A Agreement is Exposing You to Risk

    Julkaistiin: 7.2.2025
  12. What Does ICH E6 R3 Say About Returning Data to Participants?

    Julkaistiin: 5.2.2025
  13. Navigating the Ongoing HHS Communication Freeze

    Julkaistiin: 4.2.2025
  14. Ordinary People Are Changing Medicine

    Julkaistiin: 3.2.2025
  15. Trump’s First 10 Days: The Impact on Clinical Trials

    Julkaistiin: 31.1.2025
  16. Selling a Business with Issues

    Julkaistiin: 31.1.2025
  17. Breaking Down GCP E6(R3)

    Julkaistiin: 28.1.2025
  18. AdvaMed 7 rules for Essential AI Innovation

    Julkaistiin: 25.1.2025
  19. Teva’s Case Should Shape Your Pharma Strategy

    Julkaistiin: 22.1.2025
  20. 🔒 AI’s Impact on Healthcare: Liability, Ethics, and Responsibility

    Julkaistiin: 21.1.2025

1 / 20

Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm -  Helping regulators see your business the way you do. We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career. 

Visit the podcast's native language site